Breadcrumb Home Alzheimer's Disease Mergers & Acquisitions Rensselaer, Mount Sinai partner on center to tackle uncured diseases Supply Chain Change at the top for Biogen after Alzheimer's drug flops Insurance UnitedHealthcare to limit Aduhelm access Medicare Medicare finalizes policy restricting Aduhelm coverage to clinical trial patients Safety & Quality FDA reviews ALS drug after lobbying by patients, politicians Safety & Quality Patients divided over Alzheimer’s drug: Is it a ‘risk I’m willing to take’ or just a ‘magic pill’? Opinion & Editorial Will we maintain the momentum on new therapy breakthroughs? Medicare Inside the tactical tug of war over the controversial Alzheimer’s drug Patients Joint replacement pay reform hasn't hurt Alzheimer's patients Medicare Medicare limits Aduhelm coverage to clinical trials Load More Sponsored Content
